Ovarian Cancers

Advances through International Research Cooperation (GINECO, ENGOT, GCIG)

  • Eric Pujade-Lauraine
  • Isabelle Ray-Coquard
  • Fabrice Lécuru

Table of contents

  1. Front Matter
    Pages i-x
  2. Ovarian Cancer Management

    1. Front Matter
      Pages 1-1
    2. Eric Pujade-Lauraine, Florence Joly, Anne-Claire Hardy-Bessard, Isabelle Ray-Coquard, Fabrice Lecuru, Jean-Emmanuel Kurtz
      Pages 3-12
    3. Claire Sénéchal, Bruno Buecher, Antoine de Pauw, Claude Houdayer, Etienne Rouleau, Catherine Noguès et al.
      Pages 13-31
    4. Fabrice Lécuru, Charlotte Ngo, Anne Sophie Bats, Chérazade Bensaid, Pierre Combe, Eric Pujade-Lauraine et al.
      Pages 33-42
    5. Anna Fagotti, Luigi Pedone Anchora, Mara Pacciani, Giovanni Scambia
      Pages 43-58
    6. Philipp Harter, Florian Heitz, Andreas du Bois
      Pages 59-65
    7. Jean-Marc Classe, Isabelle Jaffre, Naoual Bakrin, Dominique Berton-Rigaud, Jean-Sébastien Frenel, Olivier Glehen
      Pages 67-78
    8. Enrica Bentivegna, Sebastien Gouy, Catherine Uzan, Marcos Ballester, Catherine Poirot, Emile Daraï et al.
      Pages 79-94
    9. Sandro Pignata, Sabrina Chiara Cecere
      Pages 95-112
    10. C. Falandry
      Pages 113-132
    11. Anne Floquet, Jacobus Pfisterer
      Pages 133-142
    12. Amani Makkouk, Cariad Chester, Holbrook E. Kohrt
      Pages 143-168
  3. Particular Types of Ovarian Cancers

    1. Front Matter
      Pages 169-169
    2. Masashi Takano, Satoshi Takakura, Keiichi Fujiwara
      Pages 201-209
    3. Laure de Cock, Gerlinde Averous, Philippe Barthélémy, Jean-Emmanuel Kurtz
      Pages 211-220
    4. Jubilee Brown, Michael Frumovitz
      Pages 221-232
    5. D. Berton-Rigaud, J. S. Frenel, M. Devouassoux-Shisheboran, I. Ray-Coquard
      Pages 233-246
    6. Constantine Alifrangis, Michael J. Seck
      Pages 247-259
    7. Annalisa Garbi, Maria Teresa Achilarre, Nicoletta Colombo
      Pages 261-279
    8. Patricia Pautier, Aurélie Auguste, Alexandra Leary
      Pages 281-286

About this book


This book provides an overview of the latest developments in the concepts and management of ovarian cancer. The new data presented throughout opens the way to radically different therapeutic approaches. Surgery remains the core of ovarian cancer treatment, but its ultimate goal and the standard surgical procedure have evolved, giving rise to the question of how to label expert centers for debulking surgery. Neo-adjuvant chemotherapy is becoming more popular and is also a new field for testing novel drug combinations.

Over recent years, ovarian cancer management has embraced molecular biology. It is now more correct to talk about cancers of the ovary rather than ovarian cancer, since it is not a unique disease but several entities with different molecular drivers. The significant advances in drugs targeting the microenvironment or the tumor cell DNA repair mechanisms are presented in detail together with exciting future perspectives.

All these advances would not have been possible without collaborative groups such as the GINECO group in France and their integration in wider clinical research networks at the European (ENGOT) and international (GCIG) level.


Cancer therapeutics Clinical research Onco-fertility Ovarian rare cancers Quality of Life

Editors and affiliations

  • Eric Pujade-Lauraine
    • 1
  • Isabelle Ray-Coquard
    • 2
  • Fabrice Lécuru
    • 3
  1. 1.AP-HPHôtel-DieuParisFrance
  2. 2.Centre Léon BérardUniversité Claude BernardLyonFrance
  3. 3.Chirurgie cancérologiqueHEGPParisFrance

Bibliographic information

  • DOI
  • Copyright Information Springer International Publishing Switzerland 2017
  • Publisher Name Springer, Cham
  • eBook Packages Medicine
  • Print ISBN 978-3-319-32108-0
  • Online ISBN 978-3-319-32110-3
  • Buy this book on publisher's site